Janssen (United Kingdom)
Alternate name Janssen Pharmaceutica
Parent institution Johnson & Johnson (United States)
ROR: Yes
Works count: 1,057
Citations count: 22,740
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
2019 · Philippe Moreau, Michel Attal, et al. · The Lancet
The promise and peril of chemical probes
2015 · C.H. Arrowsmith, James E. Audia, et al. · Nature Chemical Biology
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
2018 · Melanie Calvert, Derek Kyte, et al. · JAMA